Linked linear amplification

A new method for the amplification of DNA

A. A. Reyes, L. A. Ugozzoli, J. D. Lowery, J. W. Breneman, C. S. Hixson, Richard Press, R. B. Wallace

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Linked Linear Amplification (LLA) is a new nucleic acid amplification method that uses multipie cycles of primer extension reactions. The presence of nonreplicable elements in LLA primers renders primer extension products unusable as templates for further amplification, leading to linear accumulation of products. Through the use of nested primers, linear reactions can be "linked", providing total amplification yields comparable to those obtained by PCR. Methods: The LLA model predicts (a) that amplificatidn yield will approach that of PCR as the number of primers increases and (b) that the unique composition of LLA products will give lower carryover amplification efficiency compared with PCR. To test these hypotheses, the human β-globin gene was amplified by 10-, 14-, or 18-primer LLA and the yield was compared with PCR. Carryover contamination was simulated by reamplifying a dilution series of LLA or PCR products. To demonstrate the clinical utility of the method, LLA coupled with allele-specific oligonucleotide (ASO) capture was used to detect the factor V Leiden mutation in a panel of 111 DNA samples. Results: Fourteen- and 18-primer LLA gave amplification yields comparable to PCR. However, LLA carryover amplification efficiency was four orders of magnitude lower than that of PCR. The LLA-ASO assay detected the correct factor V Leiden genotype in all 111 samples. Conclusions: LLA is a robust target amplification method that is comparable to PCR in yield. However, LLA is more resistant to false results caused by carryover amplicon contamination.

Original languageEnglish (US)
Pages (from-to)31-40
Number of pages10
JournalClinical Chemistry
Volume47
Issue number1
StatePublished - 2001
Externally publishedYes

Fingerprint

Amplification
Polymerase Chain Reaction
DNA
Oligonucleotides
Alleles
Globins
Nucleic Acids
Linear Models
Genotype
Contamination
Mutation
Genes
Dilution
Assays

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Reyes, A. A., Ugozzoli, L. A., Lowery, J. D., Breneman, J. W., Hixson, C. S., Press, R., & Wallace, R. B. (2001). Linked linear amplification: A new method for the amplification of DNA. Clinical Chemistry, 47(1), 31-40.

Linked linear amplification : A new method for the amplification of DNA. / Reyes, A. A.; Ugozzoli, L. A.; Lowery, J. D.; Breneman, J. W.; Hixson, C. S.; Press, Richard; Wallace, R. B.

In: Clinical Chemistry, Vol. 47, No. 1, 2001, p. 31-40.

Research output: Contribution to journalArticle

Reyes, AA, Ugozzoli, LA, Lowery, JD, Breneman, JW, Hixson, CS, Press, R & Wallace, RB 2001, 'Linked linear amplification: A new method for the amplification of DNA', Clinical Chemistry, vol. 47, no. 1, pp. 31-40.
Reyes AA, Ugozzoli LA, Lowery JD, Breneman JW, Hixson CS, Press R et al. Linked linear amplification: A new method for the amplification of DNA. Clinical Chemistry. 2001;47(1):31-40.
Reyes, A. A. ; Ugozzoli, L. A. ; Lowery, J. D. ; Breneman, J. W. ; Hixson, C. S. ; Press, Richard ; Wallace, R. B. / Linked linear amplification : A new method for the amplification of DNA. In: Clinical Chemistry. 2001 ; Vol. 47, No. 1. pp. 31-40.
@article{15effc586d504705ac88b4cf0eaebd87,
title = "Linked linear amplification: A new method for the amplification of DNA",
abstract = "Background: Linked Linear Amplification (LLA) is a new nucleic acid amplification method that uses multipie cycles of primer extension reactions. The presence of nonreplicable elements in LLA primers renders primer extension products unusable as templates for further amplification, leading to linear accumulation of products. Through the use of nested primers, linear reactions can be {"}linked{"}, providing total amplification yields comparable to those obtained by PCR. Methods: The LLA model predicts (a) that amplificatidn yield will approach that of PCR as the number of primers increases and (b) that the unique composition of LLA products will give lower carryover amplification efficiency compared with PCR. To test these hypotheses, the human β-globin gene was amplified by 10-, 14-, or 18-primer LLA and the yield was compared with PCR. Carryover contamination was simulated by reamplifying a dilution series of LLA or PCR products. To demonstrate the clinical utility of the method, LLA coupled with allele-specific oligonucleotide (ASO) capture was used to detect the factor V Leiden mutation in a panel of 111 DNA samples. Results: Fourteen- and 18-primer LLA gave amplification yields comparable to PCR. However, LLA carryover amplification efficiency was four orders of magnitude lower than that of PCR. The LLA-ASO assay detected the correct factor V Leiden genotype in all 111 samples. Conclusions: LLA is a robust target amplification method that is comparable to PCR in yield. However, LLA is more resistant to false results caused by carryover amplicon contamination.",
author = "Reyes, {A. A.} and Ugozzoli, {L. A.} and Lowery, {J. D.} and Breneman, {J. W.} and Hixson, {C. S.} and Richard Press and Wallace, {R. B.}",
year = "2001",
language = "English (US)",
volume = "47",
pages = "31--40",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "1",

}

TY - JOUR

T1 - Linked linear amplification

T2 - A new method for the amplification of DNA

AU - Reyes, A. A.

AU - Ugozzoli, L. A.

AU - Lowery, J. D.

AU - Breneman, J. W.

AU - Hixson, C. S.

AU - Press, Richard

AU - Wallace, R. B.

PY - 2001

Y1 - 2001

N2 - Background: Linked Linear Amplification (LLA) is a new nucleic acid amplification method that uses multipie cycles of primer extension reactions. The presence of nonreplicable elements in LLA primers renders primer extension products unusable as templates for further amplification, leading to linear accumulation of products. Through the use of nested primers, linear reactions can be "linked", providing total amplification yields comparable to those obtained by PCR. Methods: The LLA model predicts (a) that amplificatidn yield will approach that of PCR as the number of primers increases and (b) that the unique composition of LLA products will give lower carryover amplification efficiency compared with PCR. To test these hypotheses, the human β-globin gene was amplified by 10-, 14-, or 18-primer LLA and the yield was compared with PCR. Carryover contamination was simulated by reamplifying a dilution series of LLA or PCR products. To demonstrate the clinical utility of the method, LLA coupled with allele-specific oligonucleotide (ASO) capture was used to detect the factor V Leiden mutation in a panel of 111 DNA samples. Results: Fourteen- and 18-primer LLA gave amplification yields comparable to PCR. However, LLA carryover amplification efficiency was four orders of magnitude lower than that of PCR. The LLA-ASO assay detected the correct factor V Leiden genotype in all 111 samples. Conclusions: LLA is a robust target amplification method that is comparable to PCR in yield. However, LLA is more resistant to false results caused by carryover amplicon contamination.

AB - Background: Linked Linear Amplification (LLA) is a new nucleic acid amplification method that uses multipie cycles of primer extension reactions. The presence of nonreplicable elements in LLA primers renders primer extension products unusable as templates for further amplification, leading to linear accumulation of products. Through the use of nested primers, linear reactions can be "linked", providing total amplification yields comparable to those obtained by PCR. Methods: The LLA model predicts (a) that amplificatidn yield will approach that of PCR as the number of primers increases and (b) that the unique composition of LLA products will give lower carryover amplification efficiency compared with PCR. To test these hypotheses, the human β-globin gene was amplified by 10-, 14-, or 18-primer LLA and the yield was compared with PCR. Carryover contamination was simulated by reamplifying a dilution series of LLA or PCR products. To demonstrate the clinical utility of the method, LLA coupled with allele-specific oligonucleotide (ASO) capture was used to detect the factor V Leiden mutation in a panel of 111 DNA samples. Results: Fourteen- and 18-primer LLA gave amplification yields comparable to PCR. However, LLA carryover amplification efficiency was four orders of magnitude lower than that of PCR. The LLA-ASO assay detected the correct factor V Leiden genotype in all 111 samples. Conclusions: LLA is a robust target amplification method that is comparable to PCR in yield. However, LLA is more resistant to false results caused by carryover amplicon contamination.

UR - http://www.scopus.com/inward/record.url?scp=0035156439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035156439&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 31

EP - 40

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 1

ER -